Carfilzomib for Refractory Antibody Mediated Rejection and Allosensitization in Heart Transplantation

L. Sacha,J. J. Teuteberg,A. Zeevi,C. Bermudez,R. Kormos,C. Ensor,J. McDyer,M. A. Shullo

The journal of heart and lung transplantation/The Journal of heart and lung transplantation（2014）

引用 6|浏览15

暂无评分

摘要

For allosensitized HTX candidates or those with AMR, a regimen of, PP, CFZ, and IVIG results in a rapid decline in Ab, as well as a decrease in their ability to activate complement. Further study is warranted on the use of CFZ for these indications.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要